WALL, NJ — (Marketwired) — 02/29/16 — BIO-key International, Inc. (OTCQB: BKYI), BIO-key International, Inc. (OTCQB: BKYI), an innovative provider of strong, interoperable biometric authentication solutions, announced that ten of the company–s healthcare partners will be highlighting BIO-key solutions at the HIMSS 2016 event February 29th – March 4th, to be held at the Sands Conference Center, Las Vegas, Nevada. Over 35,000 healthcare IT professionals will attend the four day educational and networking event.
Microsoft–s Stephen Rose, Health and Life Science Industry Lead, will feature BIO-key–s technology during his over-subscribed session “Holograms, Wearables and Future Technology: How Trends in Technology are Changing the Face of Patient Care,” held in Room 103 on Tuesday, March 1, 2016, from 11:15am – 12:15pm. Additionally, BIO-key–s healthcare partner program continues to expand, as our solutions will be highlighted at our partners– and customers– booths: Aesynt, now part of Omnicell (#5126 & #11954-3), Allscripts (#2612), Aventura (#1324), Caradigm (#5427), HealthCast (#6054), IBM (#5932) and KSI Keyboards (#7031). BIO-key also offers DEA EPCS-compliant authentication modules for Epic (#4432) and Allscripts SCM and TouchWorks, as well as Lumidigm® biometric readers from HID Global (#11941).
BIO-key–s ID Director software has a strong track record with customers who want to add a right-sized authentication solution to Epic, Allscripts, and other EHR platforms, because of its superior NIST accuracy results, simplified installation processes, and cloud-ready operational management features. At this year–s HIMSS event, the company will be introducing a new BIO-key branded, high-quality FIPS-compliant fingerprint reader for healthcare, at a breakthrough price for an EPCS-compliant scanner. One of the leading healthcare organizations in New Jersey was the first customer for this FIPS-201-compliant reader, ideally suited for two-factor authentication for EPCS. Leading healthcare organizations are replacing cumbersome authentication processes that are costly, hard to manage and deter workflow with BIO-key–s cost-efficient, easy to use, and compliant biometric platform.
BIO-key has partnered with HealthIDx to provide a cost-efficient CSP Identity Proofing and hybrid hosted/on-premises authentication solution for organizations seeking more choice and lower cost options for EPCS and non-EPCS practitioner provisioning.
BIO-key–s TruPatient positive patient identification solution is a highly scalable Patient IDaaS platform, allowing the largest organizations to automate patient identity determination at every touchpoint of a patients– relationship, including ambulatory or in-patient registration, real-time duplicate record detection, and biometric master patient index creation, as well as leveraging a SAML interface to provide authentication for access to patient portals and home health care using their personal devices.
“Our footprint in healthcare continues to grow as organizations and providers are recognizing the superior performance, accuracy, value, and end-user experience delivered by BIO-key technology,” said Jim Sullivan, BIO-key SVP of Global Sales. “Thanks to our partners– confidence in our biometric authentication modules, we are enhancing our flexible authentication software engine to add support for SAML, as well as multiple modes of authentication, including non-biometric tokens, proximity cards and push mobile authentication. We already disrupted the economics of biometric authentication with the launch of sub-$40 SideSwipe and EcoID, our BIO-key-branded line of low-cost, compact USB scanners for tablets, laptops, and workstations, as well as our new EPCS-compliant fingerprint reader. As always, BIO-key software enrolls and authenticates seamlessly as our customers mix and match any of the over 40 fingerprint scanners we support. With this end-to-end line of best-of-breed software and hardware solutions, we are able to deliver security and workflow solutions that are not only compliant and affordable, but are actually preferred by end users,” added Sullivan.
BIO-key is Revolutionizing Authentication as our easy to use biometric solutions enable convenient and secure access to information and financial transactions. We eliminate passwords, PINs tokens and cards and make it easy for enterprises and consumers to secure their devices as well as information in the cloud. Our premium finger scanning devices SideSwipe and EcoID offer market leading quality, performance and price. Now anyone can BIO-key their world! ()
Certain statements contained in this press release may be construed as “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Act”). The words “estimate,” “project,” “intends,” “expects,” “anticipates,” “believes” and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management–s beliefs, as well as assumptions made by, and information currently available to, management pursuant to the “safe-harbor” provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see “Risk Factors” in the Company–s Annual Report on Form 10-K for the year ended December 31, 2014 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.
Investor & Media Contacts:
David Collins
William Jones
Catalyst Global
212-924-9800
You must be logged in to post a comment Login